showed a trend toward a smaller infarction size following GLP-1 infusion; however, not significant difference [16] .
← all excerpts
Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis.
1
—
—